IRIS
VITALE, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.255
EU - Europa 7.785
AS - Asia 4.522
SA - Sud America 825
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 16
Totale 30.542
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.133
RU - Federazione Russa 2.458
CN - Cina 1.753
UA - Ucraina 1.531
SG - Singapore 1.171
VN - Vietnam 1.090
GB - Regno Unito 756
IT - Italia 743
SE - Svezia 674
BR - Brasile 648
DE - Germania 642
FR - Francia 521
FI - Finlandia 150
HK - Hong Kong 126
NL - Olanda 79
AR - Argentina 62
IN - India 59
PL - Polonia 52
MX - Messico 46
BD - Bangladesh 45
CA - Canada 44
JP - Giappone 43
IQ - Iraq 42
EU - Europa 39
ZA - Sudafrica 31
IE - Irlanda 30
EC - Ecuador 28
PK - Pakistan 24
ID - Indonesia 23
BE - Belgio 21
ES - Italia 21
SA - Arabia Saudita 19
AT - Austria 18
CL - Cile 18
MA - Marocco 18
TR - Turchia 18
VE - Venezuela 18
CO - Colombia 16
LV - Lettonia 15
PY - Paraguay 15
AU - Australia 12
AZ - Azerbaigian 12
TN - Tunisia 12
MY - Malesia 11
UZ - Uzbekistan 11
KE - Kenya 10
CR - Costa Rica 9
BO - Bolivia 8
BG - Bulgaria 7
ET - Etiopia 7
GR - Grecia 7
JO - Giordania 7
KR - Corea 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
KZ - Kazakistan 6
LU - Lussemburgo 6
PH - Filippine 6
PT - Portogallo 6
CH - Svizzera 5
HN - Honduras 5
IR - Iran 5
PA - Panama 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BH - Bahrain 4
DK - Danimarca 4
EG - Egitto 4
LB - Libano 4
LT - Lituania 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
HR - Croazia 3
IL - Israele 3
JM - Giamaica 3
NP - Nepal 3
PE - Perù 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MU - Mauritius 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SO - Somalia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BT - Bhutan 1
Totale 30.517
Salva come PNG Salva come JPEG
Città #
Fairfield 2.107
Woodbridge 1.882
Houston 1.681
Ann Arbor 1.318
Dallas 1.107
Ashburn 1.102
Wilmington 1.054
Chandler 897
Seattle 840
Dong Ket 774
Cambridge 689
San Jose 553
Dearborn 535
Singapore 447
Nyköping 441
Jacksonville 427
Shenzhen 396
Southend 392
Moscow 381
Beijing 331
Boardman 283
Lawrence 152
Princeton 151
The Dalles 127
Hong Kong 119
Ho Chi Minh City 111
Ogden 108
Shanghai 108
New York 102
Naples 94
Hanoi 74
San Diego 74
Los Angeles 70
Grafing 69
Norwalk 63
Düsseldorf 62
London 54
Des Moines 52
Groningen 49
Rome 45
Santa Clara 45
Chicago 44
São Paulo 44
Yubileyny 44
Munich 43
Falls Church 39
Nanjing 36
Kraków 34
Jinan 31
Dublin 29
Columbus 27
Tokyo 27
Rio de Janeiro 25
Bergamo 22
Milan 22
Shenyang 22
Helsinki 21
Hefei 19
Napoli 19
Brussels 18
Frankfurt am Main 18
Nanchang 18
Amsterdam 17
Edinburgh 17
Mexico City 17
Toledo 16
Auburn Hills 15
Baghdad 15
Council Bluffs 15
Guayaquil 15
Redwood City 15
Riga 15
Warsaw 15
Boston 14
Brasília 14
Bremen 14
Haiphong 14
Kunming 14
Washington 14
Belo Horizonte 13
Curitiba 13
Da Nang 13
Montreal 13
Salt Lake City 13
Kilburn 12
Vienna 12
Baku 11
Florence 11
Guangzhou 11
Johannesburg 11
Lahore 11
Orem 11
Stockholm 11
Changsha 10
Hangzhou 10
Lauterbourg 10
Nairobi 10
New Bedfont 10
Tashkent 10
Zhengzhou 10
Totale 20.460
Salva come PNG Salva come JPEG
Nome #
Progressive parkinsonism, balance difficulties, and supranuclear gaze palsy 632
Reliability and validity of Italian version of the Dimensional Apathy Scale in Parkinson’s Disease 326
Effects of Global Postural Reeducation on gait kinematics in parkinsonian patients: a pilot randomized three-dimensional motion analysis study 319
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 318
Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding. 314
Apathy and related Executive Syndromes in Dementia associated with Parkinson’s Disease and in Alzheimer’s Disease 287
Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale 284
Hearing Impairment in Parkinson’s Disease: Expanding the Non-Motor Phenotype 282
Abnormal eating behaviors in progressive supranuclear palsy 280
Cognitive and affective theory of mind in patients with essential tremor 274
Apathy in Parkinson’s Disease: diagnosis, neuropsychological correlates, pathophysiology and treatment 265
Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients 264
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 259
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 255
Affective theory of mind in patients with Parkinson's disease: comment 253
Impact of cognitive tasks on kinematic gait parameters in FTD patients 252
Effects of physical rehabilitation on gait pattern in parkinsonian patients with lateral trunk flexion: a three dimensional motion analysis investigation 251
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients 250
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations 250
DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients 249
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 249
Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients 248
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 246
Apoptotic mechanisms in mutant LRRK2-mediated cell death 243
Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions 239
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 236
Parkinson’s patients with or without MCI classified according to wavelet analysis of lower limb joint angles in gait cycle 235
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 235
Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia 234
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease 232
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 231
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 230
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease 228
Pathological gambling in Parkinson's disease. A comprehensive review 227
Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients 227
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 224
The "eye of the tiger" sign in pure akinesia with gait freezing 222
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease 222
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 221
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients 218
The role of embodied simulation in mental transformation of whole-body images: evidence from Parkinson's disease 218
Gender and non motor fluctuations in Parkinson's disease: a prospective study 218
Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients 217
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 217
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. 217
How does smoking affect olfaction in Parkinson's disease? 215
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 215
Electrophysiological comparison between males and females in HNPP 212
Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait 211
Season of birth and Parkinson's disease: possible relationship? 209
Gait Patterns in Parkinsonian Patients With or Without Mild Cognitive Impairment 209
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy 209
Gender and non motor fluctuations in Parkinson's disease: A prospective study 209
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 208
Cervico-oculo-Acoustic syndrome in a male with consanguineous parents 207
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 207
Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages 207
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 205
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 204
Normative data for the Montreal Cognitive Assessment in an Italian population sample 204
Teaching NeuroImages: pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 204
Early MRI findings in Acquired hepatocerebral degeneration 203
A (single case) rehabilitation program based on cueing for freezing of speech 203
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy 203
Unawareness of dyskinesias in Parkinson's and Huntington's diseases 200
Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease? 200
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2 199
Uric acid relates to dopamine transporter availability in Parkinson's disease 199
Cognitive dysfunctions in occipital lobe epilepsy compared to temporal lobe epilepsy. 199
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease 198
Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease. 197
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders. 197
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 196
Impulse control disorders and cognitive dysfunctions in patients with Parkinson's disease 196
The closing-in phenomenon in Parkinson's disease 196
Comment on Poletti et al. “Affective theory of mind in patients with Parkinson's disease”. 195
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 195
Neuropsychological profile of adult patients with non symptomatic occipital lobe epilepsies 194
Linkage exclusion in Italian families with hereditary essential tremor 192
Impulse Control Disorders induced by Rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 Cases 191
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 190
Cognitive Dysfunctions and Pathological Gambling in Patients with Parkinson’s Disease 189
Hemi-Restless Legs Syndrome induced by Clebopride 188
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 188
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 187
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease 186
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 186
The relationship between cerebral vascular disease and parkinsonism: the VADO study 186
Link between non-motor symptoms and cognitive dysfunctions in de-novo, drug naïve PD patients 183
No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients 181
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease 179
Using gait analysis' parameters to classify Parkinsonism: A data mining approach 179
The role of Vitamin D levels on neuropsychological profile of patients with Parkinson’s Disease 178
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study 178
Reply to Zappia et al.'s comment on personality and Parkinson's Disease: A meta-analysis 178
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease 177
Hearing impairment in Parkinson’s disease: expanding non motor phenotype 175
Mild Cognitive Impairment in drug-naïve PD patients is associated with cerebral hypometabolism 175
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 175
Quitting smoking: an early non-motor feature of Parkinson's disease? 173
Totale 22.317
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.345
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.028 0 0 0 0 0 0 0 0 0 0 136 892
2021/20221.528 189 151 44 402 84 102 163 120 98 95 50 30
2022/20232.611 310 164 143 315 236 436 106 312 312 75 150 52
2023/20241.229 91 44 449 46 26 106 32 81 171 61 18 104
2024/20254.479 61 360 26 109 96 401 1.121 1.358 336 238 206 167
2025/20265.228 377 863 793 480 224 112 540 524 623 577 115 0
Totale 30.833